11:38 AM EST - Aurinia Pharmaceuticals Inc. : Announced the pricing of its underwritten public offering of 22,300,000 common shares. The shares are being sold at a public offering price of $6.75 U.S. per share. The gross offering proceeds to the Company from this Offering are expected to be approximately $150.5 million U.S., before deducting underwriting discounts and commissions and other estimated offering expenses. All of the shares are being offered by the Company. The Offering is expected to close on or about March 20, subject to the satisfaction of customary closing conditions. Aurinia Pharmaceuticals Inc.
shares T.AUP are trading down $3.13 at $10.99.
